HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

NCT00192660 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-Associated Lipodystrophy Syndrome
Cardiovascular Disease

Interventions

DRUG: Lamivudine
DRUG: Stavudine
DRUG: Didanosine
DRUG: Zidovudine
DRUG: Tenofovir
DRUG: Abacavir
DRUG: Efavirenz (EFV)
DRUG: Nevirapine
DRUG: Indinavir
DRUG: Saquinavir
DRUG: Amprenavir
DRUG: Ritonavir
DRUG: Nelfinavir
DRUG: Tipranavir
DRUG: enfuvirtide (T20)

Sponsor

Kirby Institute

Collaborators

[object Object]
[object Object]